Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Janssen Biotech, Inc.
Nicholas Gueguen
| Aug 17, 2017
FDA gives Imbruvica go-ahead to aid patients with chronic graft versus host disease
Jamie Barrand
| Mar 9, 2016
FDA approves Imbruvica as first-line therapy for chronic lymphocytic leukemia
Jamie Barrand
| Sep 17, 2015
Janssen's multiple myeloma drug accepted for FDA priority review
Trending
+
Marketing
Patient Daily
| Apr 22, 2024
Medfluence Senior Director of Business Development on healthcare marketing: 'Patient experience matters more than ever in patient acquisition'
+
Pharmaceuticals
Patient Daily
| Apr 24, 2024
Researchers Look for Long-Term Hearing Loss Treatments
+
Pharmaceuticals
Patient Daily
| Apr 24, 2024
American Lung Association Report: Utah Receives Poor Grades for Ozone and Particle Pollution
+
Pharmaceuticals
Patient Daily
| Apr 23, 2024
Kentucky Father with Terminal Lung Cancer Now Cancer-Free After Innovative Double-Lung Transplant at Northwestern Medicine